what does senores mean in spanish

what does senores mean in english

what does fino senores mean in english

what does fino senores mean in spanish

Senores Pharmaceuticals Limited (SENORES) Share Price Today — ₹897.05

Senores Pharmaceuticals Limited (SENORES) live stock price is ₹897.05 with a change of -0.43% today. Listed on NSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Senores Pharmaceuticals Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Senores Pharmaceuticals Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

SENORES

NSEBSE

Senores Pharmaceuticals Limited

Healthcare· Pharmaceuticals & Biotechnology· INE0RB801010· Scrip: 544319

EN हिन्दी ગુજરાતી मराठी

₹897.05

▼ 3.90 (-0.43%)

24/4/2026, 9:45:52 am

NSE

₹897.05

▼ 3.90

-0.43%

BSE

₹900.65

▲ 17.35

+0.00%

244 trading days · 1Y period

TODAY 

Open902.00

High914.95

Low897.05

Prev Close900.95

Volume4.61Cr

Value₹1.1Cr

L: 897.05H: 914.95

52 WEEK

Low₹475.00

High₹944.50

90% of 52W range

Info

Face Value₹10

Listed2024-12-30

ISININE0RB801010

SeriesB

BSE Scrip544319

Key Metrics

1D

+1.65%

1W

+0.76%

1M

+20.52%

3M

+10.24%

6M

+22.52%

Valuation

P/E (TTM)—

P/E (Qtr Ann.)44.50

P/Sales—

Mkt Cap₹3615 Cr

Growth (QoQ)

Revenue—

PAT—

EPS—

Profitability

EBITDA Margin24.0%

Net Margin15.9%

TTM EBITDA M.—

TTM Net M.—

Dividend

Yield—

Latest DPS—

Payout Ratio—

Growth—

TTM Revenue

—

TTM EBITDA

—

TTM PAT

—

TTM EPS

—

Rev/Share

—

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	103 Cr	88 Cr	25 Cr	20 Cr	16 Cr	₹5.04

Shareholding Pattern

CURRENT — 2026-03-31

Promoter45.8%

FII3.6%

DII9.6%

Public54.2%

PROMOTER HOLDING TREND

Earnings Transcripts

Senores Pharmaceuticals Limited has informed the Exchange about Investor Presentation

15 Dec 2025NSE7K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange regarding the transcript of Earnings Confe...

13 Nov 2025NSE60K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange regarding link of Audio recording of Earni...

6 Nov 2025NSE2K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange about Investor Presentation

6 Nov 2025NSE39K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q2F...

29 Oct 2025NSE2K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange regarding schedule of Analyst/Investor mee...

13 Aug 2025NSE2K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange about Schedule of Analyst/Investor meeting...

5 Aug 2025NSE2K chars

Read →

Senores Pharmaceuticals Limited has informed the exchange regarding transcript of Earnings Conferenc...

30 Jul 2025NSE56K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange about Investor Presentation

23 Jul 2025NSE36K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q1F...

19 Jul 2025NSE2K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange regarding the Transcript of Earnings Confe...

22 May 2025NSE49K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange about Schedule of Analyst/Investor meeting...

16 May 2025NSE2K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange about Investor Presentation

16 May 2025NSE35K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q4 ...

12 May 2025NSE2K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange about Schedule of Analyst/Investor meetin...

3 Apr 2025NSE2K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange about Link of Audio Recording of Earnings ...

23 Jan 2025NSE2K chars

Read →

Senores Pharmaceuticals Limited has informed the Exchange about Investor Presentation

23 Jan 2025NSE30K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-04-23	887.60	920.40	882.25	900.95	3.45L
2026-04-22	899.00	908.95	870.40	882.50	4.48L
2026-04-21	915.00	922.00	891.00	895.70	1.82L
2026-04-20	892.00	944.50	880.95	912.40	4.39L
2026-04-17	898.80	909.55	875.05	893.85	3.14L
2026-04-16	865.00	896.50	847.65	890.30	3.90L
2026-04-15	850.00	856.55	840.10	853.85	2.43L
2026-04-13	813.10	846.90	792.70	837.10	3.58L
2026-04-10	806.10	828.00	806.10	821.40	2.22L
2026-04-09	800.00	818.10	789.25	805.35	5.45L
2026-04-08	797.00	799.00	778.80	783.25	2.08L
2026-04-07	783.95	786.50	764.05	772.30	2.13L
2026-04-02	768.00	789.95	741.90	784.25	2.14L
2026-04-01	797.00	802.00	768.85	773.55	1.72L
2026-03-27	785.90	801.40	775.00	788.00	2.43L
2026-03-25	758.30	795.00	755.20	780.80	4.18L
2026-03-24	730.00	745.00	714.15	732.40	1.20L
2026-03-20	742.00	758.00	740.45	751.60	60,185
2026-03-19	740.00	766.30	732.50	738.85	1.17L
2026-03-18	752.75	767.65	741.90	750.00	81,307
2026-03-17	748.00	757.20	739.25	752.75	49,730
2026-03-16	732.45	753.70	715.05	744.30	1.23L
2026-03-13	740.00	740.00	715.00	727.10	1.58L
2026-03-12	740.00	748.50	724.40	736.55	61,277
2026-03-11	761.00	768.00	738.60	741.95	77,682
2026-03-10	750.00	762.00	750.00	759.70	1.08L
2026-03-09	720.05	748.80	719.05	741.00	1.77L
2026-03-06	741.90	762.00	732.00	751.25	1.43L
2026-03-05	755.00	759.45	718.55	738.25	2.42L
2026-03-04	761.00	761.00	742.10	747.25	1.67L

Frequently Asked Questions

About

Senores Pharmaceuticals Limited, incorporated in 2015, is an Indian pharmaceutical company that focuses on manufacturing and developing affordable, high-quality complex generics and APIs, certified by global regulatory authorities. The company produces a range of pharmaceutical products, including tablets, with a commitment to international quality standards to meet the demands of the global healthcare industry. Notably, Senores Pharmaceuticals has positioned itself as a key player in the affordable generics market, catering to both domestic and international clients.